Pacific Green Appoints the Principal Contractor and Operations & Maintenance Provider for its Richborough Energy Park Battery Storage System in the UK

DOVER, DE / ACCESSWIRE / May 31, 2022 / Pacific Green Technologies, Inc. (the “Company” or “Pacific Green”, (OTCQB:PGTK)) announces that it has entered into an agreement with Instalcom Limited (“Instalcom”) to be the principal contractor (the “Principal Contractor Agreement”) for its 99.98 MW battery energy storage system (“BESS”) in development at Richborough Energy Park in Kent, England.

The award of this Principal Contractor Agreement, in conjunction with the battery supply agreement previously signed with Shanghai Election Gotion New Energy Technology Co., Ltd., paves the way for construction to begin in early July 2022.

Scott Poulter, Pacific Green’s Chief Executive, commented: “Instalcom has a 30 year track-record of delivering complex, large-scale energy infrastructure projects throughout the UK. We’re very pleased to have found such a partner with their capabilities, dedication and the resources to support Pacific Green as we rapidly scale up our battery energy park developments in the UK to 1.1 GW and beyond.

As well as the Principal Contractor Agreement, Pacific Green has also awarded Instalcom with an operations and maintenance contract (the “Operations & Maintenance Agreement”) to provide comprehensive operations and maintenance services for Pacific Green’s Richborough Energy Park. The Operations & Maintenance Agreement will begin at the start of Richborough Energy Park’s commercial operations via the UK’s National Grid in June 2023.

Vince Bowler, Instalcom’s Managing Director, remarked: “Instalcom is very excited to be supporting Pacific Green in the development and delivery of this low carbon technology project that will make a positive contribution to the UK’s Build Back Greener Net Zero Strategy.

Scott added: “This is another huge milestone in Pacific Green’s corporate growth into one of the world’s leading vertical energy developers. Our UK pipeline utilizes Pacific Green’s proprietary “ODCO2 Energy Development Platform” to deliver end to end capital efficient renewable energy and storage parks to the market.

About Pacific Green Technologies, Inc.:

Pacific Green Technologies, Inc. is focused on addressing the world’s need for cleaner and more sustainable energy. The Company offers BESS, Concentrated Solar Power (CSP) and Photovoltaic (PV) energy solutions to complement its marine environmental technologies and emissions control divisions.

For more information, visit Pacific Green’s website:
www.pacificgreentechnologies.com

About Instalcom Limited:

Instalcom is a Utility Contractor operating in the power, water, telecoms, rail and oil & gas sectors. Instalcom is owned by OCU Group Limited, who operate with a work force in excess of 2,000 personnel and annual revenues exceeding £210 million (US$264 million).

Notice Regarding Forward-Looking Statements:

This news release contains “forward-looking statements,” as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this news release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the construction of the 99.98 MW BESS the Company is to develop in Kent, the continuation of the Principal Contractor Agreement and the continuation of the Operations & Maintenance Agreement; and any potential business developments in the UK and future interest in the Company’s battery, solar and emissions control technologies.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, general economic and political conditions, the continuation of the Principal Contractor Agreement and the continuation of the Operations & Maintenance Agreement, and the ongoing impact of the COVID-19 pandemic. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although the Company believes that the beliefs, plans, expectations and intentions contained in this news release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all the information set forth herein and should also refer to the risk factors disclosure outlined in the Company’s annual report on Form 10-K for the most recent fiscal year, the Company’s quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

Scott Poulter, Chairman & CEO
Pacific Green Technologies
T: +1 (302) 601-4659

SOURCE: Pacific Green Technologies, Inc.

‫ شركة Billups تُوسّع أعمالها في أوروبا وتوظف كفاءات متميّزة لتلبية الطلب المتزايد على الإعلانات الخارجية

أمستردام, 31 مايو 2022/PRNewswire/ — أعلنت اليوم شركة Billups، وهي أكبر شركة خاصّة في الولايات المتحدة متخصّصة في تكنولوجيا الإعلانات الخارجية (OOH) وخدماتها المُدارة، عن إجرائها تعيينات جديدة في مناصب قيادية في الشركة لتعزيز عمليات توسيع أعمالها في جميع أنحاء أوروبا. وتشهد الشركة نموًا غير مسبوق في أعمالها في كل من الولايات المتحدة الأمريكية ومنطقة أوروبا والشرق الأوسط وإفريقيا ((EMEA؛ وذلك بعد استحواذها في بداية هذا العام على شركتيْن متخصّصتيْن في تكنولوجيا الإعلانات، وتعاقدها مع عملاء جدد، وتسجيلها لبراءات اختراع في مجال تقنيات “الذكاء المكاني”.

وفي تعليقه على هذا الخبر، قال بنجامين بيلوبس، الشريك المؤسس لشركة Billups : “لقد كان عام 2021 من أفضل الأعوام بالنسبة لشركة Billups منذ أن قمتُ أنا وهيذر [بيلوبس] بتأسيسها منذ 20 عامًا تقريبًا. وإنّ أعمال شركتنا تنمو حاليًا بوتيرة متسارعة؛ لذا، فقد أصبحت عمليات الاستحواذ والتوسّع أمرًا مهمًا لنا، لكنّ الأمر الأكثر أهمية هو ما نقوم به من تعيين لموظفين ذوي كفاءات ومواهب لإحداث نقلة نوعية في قطاع الإعلانات الخارجية في المستقبل”.

وبعد انطلاق أعمال شركة Billups في أوروبا في الخريف الماضي، تحت قيادة أندرو برونتون، العضو المنتدب لمنطقة أوروبا والشرق الأوسط وشمال إفريقيا، عقدت الشركة العديد من الشراكات مع مجموعة من العلامات التجارية العالمية الشهيرة بهدف تطوير إعلاناتها الخارجية؛ حيث تُعدّ هذه الإعلانات عنصرًا رئيسيًا في المزيج التسويقي لهذه العلامات التجارية. ومع تزايد استثمارات الجهات المُعلنة ووكالات الإعلان في الإعلانات الخارجية ( (OOH ، والإعلانات الخارجية الرقمية ( (DOOH ، والإعلانات الخارجية الرقمية المُبرمجة (pDOOH) ؛ أجرت شركة Billups تعيينات جديدة شملت المناصب القيادية التالية:

  • أماندا بينغهام، مديرة حسابات، منطقة أوروبا والشرق الأوسط وإفريقيا: عملت أماندا في شبكة تلفزيون بوميرانغ ( Boomerang ) قبل أن تنضم مجدّدًا إلى فريق عمل Billups في أمستردام للإشراف على عمليات التخطيط الإستراتيجي والتوظيف وتحليل البيانات في جميع أرجاء المنطقة.
  • أندريس كاربالو باشيكو، مدير حسابات، منطقة أوروبا والشرق الأوسط وإفريقيا: يمتلك أندريس خبرة تكنولوجية ورقمية واسعة، ويشرف على التخطيط الإستراتيجي والاستثمارات وإدارة العمليات في شبه جزيرة أيبيريا وأوروبا الجنوبية.
  • فينتي بارتون، مديرة حسابات، منطقة أوروبا والشرق الأوسط وإفريقيا: تمتلك فينتي خبرة عالمية قوية في مجال الإعلانات الخارجية الإبداعية القائمة على التكنولوجيا، وقد انضمت إلى فريق عمل الشركة في لندن لتطوير عمليات التخطيط الإستراتيجي والعلاقات مع العملاء في المملكة المتحدة ومنطقة أوروبا والشرق الأوسط وإفريقيا.
  • ثورستن نورمان، مدير حسابات، منطقة أوروبا والشرق الأوسط وإفريقيا: يعمل ثورستن -منذ انطلاق أعمال الشركة في فرانكفورت- على جذب عملاء جدد وإدارة عمليات التخطيط والتوظيف في ألمانيا ومنطقة أوروبا الشرقية.
  • فالنتين برييتو، كبير مديري الأعمال، منطقة أوروبا والشرق الأوسط وإفريقيا: يتولى فالنتين إدارة قسم شركاء الأعمال وعلاقات العملاء في الشركة باحترافية؛ حيث يقود عملية تنمية أعمال الشركة في جميع أرجاء منطقة أوروبا الغربية.
  • لورينزو كونتي، مدير الحسابات والشراكات، منطقة أوروبا والشرق الأوسط وإفريقيا: يمتلك لورينزو خبرة واسعة في إدارة عمليات التسويق، وتطوير الأعمال، والشراكات مع العلامات التجارية الفاخرة في قطاع الموضة والأزياء، ويشرف على الإستراتيجية والشراكات الإعلامية في منطقة أوروبا الجنوبية والشرق الأوسط.

يعمل لدى شركة Billups أكثر من 140 موظفًا في أكثر من 26 مكتبًا في جميع أنحاء العالم، وللشركة شراكات مع كبرى العلامات التجارية في قطاعات التكنولوجيا، والموضة والأزياء، والمالية، والرعاية الصحية، والسلع الاستهلاكية المعبأة ( (CPG ، والترفيه، ومطاعم الوجبات السريعة ( (QSR ، والتجزئة، والمشروبات الكحولية، والسياحة، والعملات المشفرة.

عن شركة Billups
تسعى شركة Billups إلى إحداث نقلة نوعية في قطاع الإعلانات الخارجية من خلال تطوير عمليات التخطيط للحملات الإعلانية الخارجية وتحديد الأماكن المُثلى لعرض الإعلانات. وتحتل الشركة مكانة متميّزة في هذا القطاع من خلال مزج أفكارها الفنّية الإبداعية مع أحدث الأساليب العلمية والتقنيات المتقدّمة؛ وهو ما يمكّن الشركة من تزويد عملائها بحلول علمية حاصلة على براءات اختراع لإقامة حملات إعلانات خارجية فعّالة تستهدف جماهير محدّدة، وتوفير قياسات دقيقة لنتائج هذه الحملات، بالإضافة إلى محرّك توصية قائم على تقنيات الذكاء الاصطناعي. كما توفر شركة Billups -التي تأسّست في عام 2003- للجهات المُعلنة ووكالات الإعلان ومالكي وسائل الإعلام منصة تعمل بطريقة آلية لإقامة أقوى الحملات الإعلانية الرقمية وأكثرها فعالية. لمزيد من المعلومات عن الشركة، يُرجى زيارة موقعها الإلكتروني: www.billups.com .

للتواصل الإعلامي
جيف جان
مدير إدارة تطوير الأعمال
marketing@billups.com

Billups Accelerates European Expansion and Taps Top Talent to Tackle Growing OOH Demand

رابط الشعار:  https://mma.prnewswire.com/media/1826940/Billups_Logo.jpg

MGI and King Abdullah International Medical Research Center Announce Partnership for Genomic Research

The new agreement will enable cutting-edge research aimed at preventing disease and improving health while supporting specialized training of healthcare professionals and scientists.

RIYADH, Saudi Arabia, May 31, 2022 /PRNewswire/ — Global life science innovator MGI Tech Co. Ltd. (MGI) and King Abdullah International Medical Research Center (KAIMRC) have signed a Memorandum of Understanding (MOU) to engage in a strategic collaboration in the fields of genomic science and biotechnology.

MGI and KAIMRC will lead an international collaborative research program powered by MGI’s innovative technologies in areas such as genomics and bioinformatics for health and diseases while driving the development of local talent in these fields.

Driven by MGI’s proprietary DNBSEQ™ technology*, the strategic collaboration will utilize MGI’s platform to improve genome sequencing and data quality across a wide range of applications, including human genome sequencing, transcriptome sequencing, infectious diseases, and microbial organisms research, such as COVID-19 monitoring and epidemiology.

The MOU envisions the establishment of a high-throughput sequencing center in KAIMRC which will house MGI’s leading technology platforms, including DNBSEQ™ sequencing*, laboratory automation, and bioinformatics products. As part of the collaboration, MGI and KAIMRC will also join forces across several other areas such as business development, marketing, and public communications, and education to enhance genomic research and development, as well as create the awareness in the coming genomic era.

Commenting on the collaboration, Prof. Ahmed Alaskar, Executive Director, KAIMRC said: “MGI is an invaluable strategic partner in our journey towards establishing state-of-the-art genomic sequencing capabilities in Saudi Arabia. Precision medicine is the future of healthcare and this partnership paves the way for new and innovative approaches in this field.”

Dr. Roy Tan, General Manager of MGI Asia Pacific said: “We are extremely proud and excited to partner with KAIMRC on this important initiative aimed at improving people’s health. We look forward to integrating our expertise with KAIMRC to deliver a positive impact on health and wellness that will benefit not only just Saudi Arabia but also the rest of the world.”

Established in 2016, MGI is a leading innovator in life sciences. Employing over 1,700 employees worldwide, MGI operates in more than 70 countries and regions, serving more than 1,000 customers with world-class products and services. MGI innovative products include Genetic Sequencer*, Laboratory Automation System, and Robotic Ultrasound System, supporting customers globally in life science research, medicine and healthcare.

About MGI

MGI Tech Co. Ltd. (MGI), headquartered in Shenzhen, is committed to building core tools and technology to lead life science through intelligent innovation. Based on its proprietary technology, MGI focuses on research & development, production and sales of sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers*, and its multi-omics platforms include genetic sequencing*, medical imaging, and laboratory automation. MGI’s mission is to develop and promote advanced life science tools for future healthcare. For more information, please visit the MGI website or connect with us on TwitterLinkedIn or YouTube.

*Unless otherwise informed, StandardMPS and CoolMPS sequencing reagents, and sequencers for use with such reagents are not available in Germany, USA, Spain, UK, Hong Kong, Sweden, Belgium, Italy, Finland, Czech Republic, Switzerland, Portugal and Austria.

About KAIMRC

King Abdullah International Medical Research Center’s (KAIMRC) purpose is to transform lab results into products that improve the quality of life, while training skillful researchers within the healthcare community. KAIMRC is a young and thriving organization that has evolved to accomplish immeasurable success in a short period of time. At KAIMRC, we pursue translational research to facilitate the advancement of biomedical and clinical research and knowledge into practical solutions and to contribute to developing a thriving medical biotechnology ecosystem.

Conagen’s New Dihydro Resveratrol Made By Clean Bioconversion Inspires Novel Products and Drives Market Growth

Bedford, Mass., May 31, 2022 (GLOBE NEWSWIRE) — Massachusetts-based biotech Conagen announces the development of a new scalable natural compound, dihydro resveratrol, for use in industrial and human health applications. Conagen’s dihydro resveratrol is made by bioconversion from p-coumaric acid (pCA), a natural preservative Conagen produced by precision fermentation.

The same proprietary bioconversion technology used to make dihydro resveratrol can be used to make resveratrol and other polyphenol class molecules. Both compounds are natural metabolites of plants, such as berries and grapes, and are commonly found in red wine.

Because resveratrol and dihydro resveratrol exist in only very small quantities in plants, cultivation, extraction, and purification are very inefficient, using more land, water, and energy. Instead, Conagen starts with pCA made using fermentation of microorganisms. Bioconversion of pCA allows Conagen to use a much smaller footprint to make dihydro resveratrol and related compounds.

“The development of dihydro resveratrol demonstrates Conagen’s strong capability to manufacture and deliver innovative and versatile compounds for multiple large-scale applications,” said Casey Lippmeier, vice president of innovation. “Our proprietary bioconversion and precision fermentation capabilities enable the production of sustainable high-quality polyphenols for use in novel products which drive the growth of new markets.”

Resveratrol molecules in the category of polyphenols possess rich antioxidant properties. Its anti-inflammatory and antioxidant activity are linked to protective effects against heart disease, diabetes, cancer, and cognitive decline. Conagen has announced several polyphenol products over the past few years, such as Taxifolin BC-DHQ® (dihydroquercetin), kaempferol, Rosaval™  rosmarinic acid, and hydroxytyrosol, establishing a strong leadership in the development of polyphenol compounds.

In addition to their importance in human health applications for improving the quality of life, dihydro resveratrol and resveratrol are also important industrial intermediates. They offer valuable use in many industrial applications, such as plastic additives, paints, resins, polymers, and high-temperature-resistant biomaterials.

Conagen is working with multiple industrial partners to develop novel applications of dihydro resveratrol, resveratrol, and related compounds.

About Conagen

Conagen is a product-focused, synthetic biology R&D company with large-scale manufacturing service capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

Attachment

Ana Arakelian, Head of Public Relations and Communications
Conagen
+1.781.271.1588
ana.arakelian@conagen.com

Hitachi Energy wins order from Deutsche Bahn to deliver one of the most powerful converter stations in the world

The Thyrow converter plant will convert electricity from the public three-phase distribution network to a frequency of 16.7 Hz and feed it into the traction current network

Zurich, Switzerland, May 31, 2022 (GLOBE NEWSWIRE) — Hitachi Energy, the global technology and market leader in power grids, announced today that it has won an order from Deutsche Bahn to provide a 120 megawatt (MW) converter station which enables DB Energie to secure power supply for the Greater Berlin rail network. The network serves a metropolitan population of around 3.5 million people and is the hub for multiple high-speed train services to cities throughout Germany and neighboring countries.

The Thyrow converter station, south of Berlin, will enable Deutsche Bahn to convert electricity from the public three-phase power distribution grid, which operates at a frequency of 50 hertz (Hz) to 16.7 Hz, and feed it into the rail power grid used to power trains and rail infrastructure.

The order follows one awarded last year by Deutsche Bahn to Hitachi Energy for the 160 MW Delitz converter station in the greater Halle/Leipzig area, which will be one of the most powerful converter stations for rail power worldwide.

“We are delighted that Deutsche Bahn has selected Hitachi Energy as partner of choice to secure the 16.7 Hz power supply for their rail network,” said Niklas Persson, Managing Director of Hitachi Energy’s Grid Integration business. “This is an excellent example of how we collaborate together with customers and partners to accelerate the energy transition and advancing a sustainable energy future for all.”

The Hitachi Energy solution for the Thyrow converter station comprises three compact 40 MW static frequency converter modules, which use Hitachi Energy’s advanced power semiconductors to provide a steady and reliable power supply at maximum availability and with minimal electrical losses. The solution includes a 30-year service contract and a digitalization package to provide Deutsche Bahn with condition-based and reactive maintenance and data insights into the system status of the converter station over the life cycle.

Hitachi Energy is the world’s leading supplier of grid integration and power quality solutions, including rail converter stations and the integration of renewable energy into power transmission systems.

Notes to the Editor

Static frequency converters

Rail frequency converter stations are based on static frequency converters (SFC). They connect three-phase power distribution or transmission grids, which typically operate at 50 or 60 Hz, with single-phase railway power grids, which operate at 16.7, 25, 50 or 60 Hz. Besides the transfer of active power, the SFC can also control reactive power in both grids independently. It responds immediately to grid faults and enables a smooth and interruption-free transition to island mode during an outage.

Power electronics

SFCs are based on Hitachi Energy’s power electronics. These integrated gate-commutated thyristors (IGCTs) will be part of this solution. They maintain grid stability and power quality by responding rapidly to frequency fluctuations and grid disturbances. Power electronics are an integral part of many Hitachi Energy technologies, including high-voltage direct current (HVDC) and flexible AC transmission systems (FACTS).

About Hitachi Energy Ltd.

Hitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We serve customers in the utility, industry and infrastructure sectors with innovative solutions and services across the value chain. Together with customers and partners, we pioneer technologies and enable the digital transformation required to accelerate the energy transition towards a carbon-neutral future. We are advancing the world’s energy system to become more sustainable, flexible and secure whilst balancing social, environmental and economic value. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries. Headquartered in Switzerland, we employ around 38,000 people in 90 countries and generate business volumes of approximately $10 billion USD.

About Hitachi, Ltd.

Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers’ and society’s challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products, under the business structure of Digital Systems & Services, Green Energy & Mobility, Connective Industries and Automotive Systems. Driven by green, digital, and innovation, we aim for growth through collaboration with our customers. The company’s consolidated revenues for fiscal year 2021 (ended March 31, 2022) totaled 10,264.6 billion yen ($84,136 million USD), with 853 consolidated subsidiaries and approximately 370,000 employees worldwide. For more information on Hitachi, please visit the company’s website at https://www.hitachi.com.

Attachment

Rebecca Bleasdale
Hitachi Energy Ltd.
+41 78643 2613
rebecca.bleasdale@hitachienergy.com